Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Rath, E; Bonelli, M; Duftner, C; Gruber, J; Mandl, P; Moazedi-Furst, F; Pieringer, H; Puchner, R; Flick, H; Salzer, HJF; Weiss, G; Winkler, S; Skvara, H; Moschen, A; Hofer, H; Feurstein, J; Sautner, J.
National consensus statement by the Austrian Societies for Rheumatoloay, Pulmonoloay, Infectiology, Dermatology and Gastroenterology regarding the management of latent tuberculosis and the associated utilization of biologic and targeted synthetic DMARDS (disease modifying antirheumatic drugs)
Z RHEUMATOL. 2022;
Doi: 10.1007/s00393-022-01274-6
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
-
Flick Holger
-
Moazedi-Fürst Florentine
-
Salzer Helmut J. F.
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- This nationwide Austrian consensus statement summarizes the recommendations on the management of latent tuberculosis by treatment with biologic and targeted synthetic DMARDs. The essential questions with respect to screening and preventive treatment were discussed by experts from the disciplines of rheumatology, pneumology, infectious diseases, dermatology and gastroenterology, based on the available data, and then a joint consensus was formed by agreement. This involved a differentiated discussion on the various forms of treatment, and clear recommendations were formulated.
- Find related publications in this database (Keywords)
-
Screening
-
Preventive treatment
-
Recommendations
-
Risk reduction
-
Drugs